WallStSmart
CURX

Curanex Pharmaceuticals Inc Common Stock

NASDAQ: CURX · HEALTHCARE · BIOTECHNOLOGY

$4.41
-0.67% today

Updated 2026-11-20

Market cap
$7.53M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-7.80
Dividend yield
—
52W range
$4 – $13
Volume
0.0M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
8.5
Quality
A
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
18.0
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →248 stocks currently score above 75

Price targets

Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—

Price chart

Stock snapshot

Strengths
+ Altman Z 18.01 — safe zone
+ Debt/equity 0.21x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-1.36M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$26000.00$0.00$0.00$0.00—
Net income$-20233.00$-19198.00$-361506.00$-4.23M$-2.82M
EPS————$-7.80
Free cash flow$3336.00$-120.00$-555580.00$-10.48M$-1.36M
Profit margin-77.82%————

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CURX$7.53M234.33.05.08.5—Avoid
LLY$1.27T749.310.05.06.0—Strong Buy
JNJ$682.52B544.78.52.75.5-84.03%Buy
ABBV$520.47B776.79.04.05.0-79.80%Strong Buy
UNH$363.01B626.76.05.35.5-3.96%Buy
MRK$362.27B423.36.52.05.0-56.01%Hold

Smart narrative

Curanex Pharmaceuticals Inc Common Stock trades at $4.41. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 18.01, it sits in the safe zone.

Frequently asked questions

What is Curanex Pharmaceuticals Inc Common Stock's stock price?

Curanex Pharmaceuticals Inc Common Stock (CURX) trades at $4.41.

Is Curanex Pharmaceuticals Inc Common Stock overvalued?

Curanex Pharmaceuticals Inc Common Stock carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Curanex Pharmaceuticals Inc Common Stock's Altman Z-Score is 18.01, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE-89.59%
Beta—
50D MA$4.97
200D MA$6.10
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—